2,354 material Form 8-K filings that 2,004 companies we cover made with the SEC in November 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). 1,081 of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Z Squared Inc. elected Jeffery Harris, its Chief Technology Officer, as a director effective November 3, 2026, filling the seat left vacant by Michelle Burke's May 22, 2026 resignation. Harris is an employee and executive officer, so he is not independent, but three of the five directors remain independent, keeping a majority under Nasdaq rules. He receives no additional director compensation.
Jeffery Harris, age 40, elected director effective November 3, 2026, filling the vacancy left by Michelle Burke's resignation
Board remains at five directors; three (Adam Sohn, Bryan Fuerst, Kenneth Cooper) are independent
Harris is not named to any board committee and receives no additional director compensation
Filing notes ongoing commercial relationships with Paradox Infrastructure LLC and Paradox Energy LLC, in which Harris holds membership interests
Picard Medical's board appointed Richard Fang, Ph.D., as permanent, full-time Chief Executive Officer effective October 28, 2026; he had served as interim CEO since June 18, 2026 and remains Chairman. The filing also discloses related-person loans from a Fang-affiliated entity, and the company had not received the $1.0 million of external funding that would have kept the earliest of those loans from coming due, so they are now payable on terms yet to be determined.
Richard Fang, Ph.D., appointed permanent CEO effective October 28, 2026; salary remains $0.4 million with no new compensation arrangement
Fang-affiliated fund lent $0.5 million at 0% interest under five loans from July 29 to October 16, 2026; no principal repaid as of October 29, 2026
As of October 29, 2026, no external funding of at least $1.0 million received; earliest loans now due on payment terms to be determined
Separate $0.7 million loan from Fang Family Fund I, LLC at 6% interest, due February 28, 2027
Avantor's compensation committee approved a special long-term incentive award for Executive Vice President and Chief Legal and Compliance Officer Claudius Sokenu, recognizing his work in litigation, regulatory management, dispute resolution and corporate governance. The award is 62,305 restricted stock units granted October 31, 2026, under the company's 2019 Equity Incentive Plan. The filing describes a routine compensation grant that does not change executive leadership and gives no financial results.
Award: 62,305 restricted stock units granted October 31, 2026, to Claudius Sokenu
Vesting: equal installments on the first three anniversaries of the grant date, subject to continued employment
Approved by the Compensation and Human Resources Committee on October 30, 2026
Enovix disclosed that Arthi Chakravarthy, its Chief Legal Officer and Corporate Secretary, has departed the company, effective October 30, 2026. The filing does not give a reason for the departure or name a successor.
Arthi Chakravarthy, Chief Legal Officer and Corporate Secretary, departed effective October 30, 2026
Filing dated November 3, 2026, signed by Ryan Benton, Interim Chief Executive Officer
No successor or replacement arrangement is named in the filing
Concentrix Corporation announced that Chinnu Susan Varghese will succeed Andre Valentine as Chief Financial Officer effective December 1, 2026. Mr. Valentine will remain in the role in the near term and stay through the second quarter of fiscal 2027 to support the transition.
Chinnu Susan Varghese joins Concentrix on November 9, 2026 and becomes CFO on December 1, 2026.
Andre Valentine stays on as CFO in the near term and is expected to remain with the company through the second quarter of fiscal 2027.
Ms. Varghese previously was Senior Vice President and Group Controller at Marelli and CFO, Global Growth Markets at Cognizant.
On October 28, 2026, Optimum Communications increased its board from nine to eleven directors and appointed Elizabeth Abrams and Daniel Silvers, both determined to be independent. The board also created a special committee of these two directors with authority to evaluate potential financing, restructuring, or recapitalization transactions and conflict-of-interest matters involving related parties.
Board size increased from nine to eleven directors effective October 28, 2026.
Each new director will receive a monthly fee of $75,000 under an Independent Director Agreement.
Silvers' brother is a partner at Ropes & Gray LLP, which the company paid approximately $11 million for legal services since January 1, 2025.
Special Committee members are Abrams and Silvers, with delegated power to review potential strategic and financial transactions.
IFF's board approved one-time equity and cash incentive awards for executives, including the CEO and CFO, tied to closing the previously announced sale of its Food Ingredients business. The board also adopted amended bylaws that allow stockholder meetings to be held solely by remote communication.
Named executive awards total $700,000 for CEO J. Erik Fyrwald (RSUs with three-year cliff vesting), CFO Michael DeVeau, and President Leticia Gonçalves Lourenço, plus $350,000 for Yuvraj Arora
No award vests or is paid unless the Food Ingredients sale closes; awards are forfeited if the agreement is terminated
Amended and restated bylaws took effect October 28, 2026 and permit remote-only stockholder meetings
Accendra Health's Executive Vice President and Chief Operating Officer, Perry Bernocchi, will cease to be an executive officer under a transition agreement dated October 29, 2026, and serve as Strategic Advisor to the CEO until December 31, 2026, unless his employment ends earlier. He keeps his current base salary and remains eligible for his 2026 annual bonus at target and for applicable severance, which matters to shareholders as a senior operating leadership change.
Perry A. Bernocchi, EVP and Chief Operating Officer, ceases to be an executive officer under agreement dated October 29, 2026
Serves as Strategic Advisor to the Chief Executive Officer until December 31, 2026, unless employment ends earlier
Keeps current base salary and remains eligible for 2026 annual bonus at current target
Remains eligible for severance under Officer Severance Policy or change of control agreement, as applicable
Ring Energy disclosed that director Richard Harris is retiring from its board of directors, effective October 28, 2026. The filing states his decision was not the result of any dispute or disagreement with the company on its operations, policies, or practices.
Richard Harris notified the board on October 28, 2026 of his retirement.
Retirement is effective October 28, 2026.
Filing states no dispute or disagreement with the company led to the decision.
8-K signed by CFO Sundip S. Johl on November 3, 2026.
Guardant Health increased its board to 11 seats and appointed Kevin R. Sayer, former Dexcom CEO, as a Class II director effective November 2, 2026. The company also named Robert A. Parks as Chief Accounting Officer and principal accounting officer on the same date, replacing no named predecessor in the filing. The changes add board and finance leadership but the filing discloses no financial results.
Kevin R. Sayer, 68, appointed Class II director effective November 2, 2026, with a term expiring at the 2029 Annual Meeting
Sayer to receive a restricted stock unit award valued at $500,000 and a $60,000 annual cash retainer
Robert A. Parks, 54, appointed Chief Accounting Officer and principal accounting officer; previously CAO of Fortrea Holdings Inc. from August 2024 to August 2026
Wolverine World Wide disclosed a separation agreement with Susie Kuhn, who stopped serving as President, Active Group on September 21, 2026. The agreement, effective October 31, 2026, provides severance, benefits, a prorated fiscal 2026 bonus payable if at all, and restrictive covenants on her. The filing does not state any financial impact on the company's results.
Kuhn ceased serving as President, Active Group on September 21, 2026, as previously disclosed.
Severance equals one year of base salary, paid bi-weekly, plus health care continuation benefits.
Prorated fiscal 2026 bonus is payable based on actual company performance, if at all, after active employees are paid.
Non-compete runs through October 31, 2027; non-solicitation runs through September 21, 2027.
ACM Research, Inc. announced that Yue Ma began work as Chief Operations Officer effective October 1, 2026, under an offer letter with a $375,000 base salary and a $100,000 target annual bonus. The filing also discloses equity grants and a sign-on bonus, which give the company a clear view of the cost of the appointment.
Base salary of $375,000 and target annual bonus of $100,000
Stock option for 100,000 Class A shares at $83.58 per share, vesting from October 1, 2027
Restricted stock units for 13,470 shares, vesting in four annual installments; one-time $50,000 sign-on bonus and relocation benefits up to $150,000
U.S. GoldMining appointed John DeLucchi to its Board of Directors on November 2, 2026, filling a vacancy and making him Chair of the Audit Committee. The company says this restores compliance with Nasdaq's audit committee requirements, which it had lost after a director's resignation, as previously reported by Nasdaq notice on August 27, 2026.
Board appointment effective November 2, 2026, filling the vacancy left by Aleksandra Bukacheva's resignation
Nasdaq notice dated August 27, 2026 cited non-compliance with Listing Rule 5605; company says compliance is now regained
DeLucchi receives a US$10,000 annual director retainer plus US$2,500 for Audit Committee chair, and an option on 10,000 shares at $5.71
SiriusPoint Ltd. announced that John Sauerland, a former Progressive Insurance Chief Financial Officer with more than 35 years of insurance industry experience, will join its Board of Directors effective January 1, 2027. The Board has determined he is independent and an audit committee financial expert, and he will receive the same director compensation as the company's other non-employee directors.
Appointment effective January 1, 2027, as a Class I director with a term running until the 2029 annual general meeting of shareholders
Previously served as Chief Financial Officer at Progressive Insurance and has more than 35 years of insurance industry experience
Board determined he is independent under NYSE and Exchange Act requirements and qualifies as an audit committee financial expert
No committee appointments yet; the company will file an amendment to this Form 8-K when they are determined
Pfizer's board unanimously elected Cecile Guegan as Chief Financial Officer and Executive Vice President, effective November 1, 2026, after she served as interim CFO since August 16, 2026. The filing sets her base salary at $1,300,000 and her target annual cash incentive at $1,300,000, and it does not report any financial results or change to guidance.
Cecile Guegan appointed CFO and Executive Vice President, effective November 1, 2026; interim CFO since August 16, 2026
Annual base salary of $1,300,000
Annual target cash incentive of $1,300,000, equal to 100% of base salary
She will oversee all corporate finance functions, including audit, treasury, investor relations and tax
On October 30, 2026, MacroGenics increased its Board from ten to eleven members and appointed Michael Vasconcelles and Emil Kuriakose as independent directors, effective that day. Both were also placed on the Science and Technology Committee and will receive director compensation, including initial option and restricted stock unit awards, which adds modest equity dilution for shareholders. The filing reports no financial results.
Board size increased from ten to eleven members, approved October 30, 2026.
Michael Vasconcelles named Class II Director and Emil Kuriakose named Class III Director, effective October 30, 2026.
Each director receives an option for 44,000 shares and a restricted stock unit grant for 7,500 shares under the 2023 Equity Incentive Plan.
Both directors were determined to be independent and joined the Science and Technology Committee.
Willis Towers Watson said Steven Alcock, 47, will succeed Joseph Kurpis as Principal Accounting Officer and Controller, effective April 1, 2027, as Kurpis retires. Alcock has been Head of Finance, International since January 2022 and has been CFO of Willis Limited, a U.K. subsidiary, since December 2025. The change is a routine succession in a finance role and does not include any disclosed change to financial results or guidance.
Steven Alcock, 47, appointed to succeed Joseph Kurpis as Principal Accounting Officer and Controller
Effective date: April 1, 2027
Alcock joined the company in 1997 and has been Head of Finance, International since January 2022
Filing states no arrangements with other persons and no family relationships with directors or executive officers
BNB Standard Corporation increased its board from six to seven directors and appointed Anthony Scaramucci, founder and Managing Partner of SkyBridge Capital, effective November 3, 2026. The appointment fulfills a provision of the company's June 23, 2026 cooperation agreement with YZiLabs, under which the parties agreed to add a new independent director. The filing reports no financial results or changes to company operations.
Board size increased from six to seven directors; Scaramucci fills the new seat effective November 3, 2026.
Appointed under Section 1(c) of the Cooperation Agreement dated June 23, 2026 with YZiLabs Management Ltd.
Board has not assigned Scaramucci to any committee; the company states he is independent under Nasdaq standards.
Scaramucci is scheduled to host a fireside chat with CEO Alex Odagiu at the SALT Conference in London on November 4, 2026.
On November 3, 2026, First American Financial Corporation appointed Darryl D. Button to its Board of Directors, and he has not yet been named to any board committee. Button has been president and CEO of Pacific Mutual Holding Company since April 2022 and previously served as First American's chief financial officer from 2017 to 2021, so the appointment adds a director with prior company finance experience and current insurance leadership.
Darryl D. Button appointed to the board on November 3, 2026
No committee assignments yet, per the filing
Button has been president and CEO of Pacific Mutual Holding Company since April 2022
Previously served as First American's chief financial officer from 2017 to 2021
At its October 28, 2026 annual meeting, five director nominees did not receive a majority of votes cast and offered conditional resignations, which the board will accept or reject and announce within 90 days after certification. Shareholders also voted 956,752 against versus 422,593 for the say-on-pay proposal, and Executive Vice President Jamie Suarez is leaving his officer role after October 30, 2026, with employment ending November 22, 2026.
Five nominees did not win a majority: Andrew Alfano, Lockie Andrews, Nancy Benacci, Susan Lintonsmith and Michael Mansbach.
Say-on-pay vote: 956,752 against, 422,593 for and 76,907 abstain, with 592,063 broker non-votes.
The board will publicly announce its decision on the offered resignations within 90 days after the election results are certified.
Jamie Suarez's officer role ends at the end of October 30, 2026; his employment ends November 22, 2026, with severance subject to a release of claims.
Erie Indemnity CEO Timothy G. NeCastro retired on November 2, 2026, earlier than the previously announced December 31, 2026 date, citing personal reasons. Brian W. Bolash, the company's Executive Vice President, was appointed Interim President and CEO effective November 3, 2026, while the board's Nominating and Governance Committee continues its search for a permanent CEO.
Timothy G. NeCastro retired as President and CEO on November 2, 2026, accelerated from December 31, 2026 for personal reasons.
Brian W. Bolash, age 61, named Interim President and CEO effective November 3, 2026.
Bolash has been Executive Vice President since January 2022 and Secretary and General Counsel since October 2019.
No immediate compensation changes were reported; the board is still searching for a next President and CEO.
At its October 28, 2026 annual meeting, Mercury Systems shareholders elected Jean Bua, Gerard J. DeMuro, and Scott Ostfeld as Class II directors for three-year terms ending in 2029, and approved an advisory say-on-pay vote and the ratification of KPMG LLP as auditor for fiscal 2027. The board also elected William L. Ballhaus as Chairman and Barry R. Nearhos as Lead Independent Director, and set its committee assignments for the coming year.
Director votes for: Bua 50,797,517; DeMuro 50,807,272; Ostfeld 49,338,401, with Ostfeld also receiving 6,702,156 withheld votes
Advisory say-on-pay vote: 49,014,946 for and 7,002,993 against
KPMG LLP ratified for fiscal 2027: 56,919,146 for and 1,168,395 against
Board on October 28, 2026 named William L. Ballhaus Chairman and Barry R. Nearhos Lead Independent Director
Astec Industries announced that director Linda Knoll will resign from the Board effective December 14, 2026, and that the Board appointed John Keating as an independent director effective December 11, 2026, with a seat on the Audit Committee. The filing states Ms. Knoll's resignation was not the result of any disagreement with the company. The change is a board composition update and includes no financial results.
Linda Knoll notified the Board on October 29, 2026 of her resignation from the Board and all committees, effective December 14, 2026.
The Board appointed John Keating, age 65, effective December 11, 2026, with an initial term expiring at the 2027 annual meeting.
Mr. Keating joins the Audit Committee and was deemed independent; he previously served as an executive at CRH plc from 1994 to 2026.
Trimble's board appointed Matthew C. Brown, currently Chief Financial Officer of Tenable Holdings, as a director effective November 2, 2026, and placed him on the Audit Committee. The filing does not name any change in an executive role at Trimble, and it describes a standard non-employee director compensation arrangement and indemnification agreement.
Board appointed Matthew C. Brown as a director effective November 2, 2026.
Brown was also appointed to the Audit Committee of the Board on the same date.
Brown has been CFO of Tenable Holdings, Inc. since August 2025 and was CFO of Altair Engineering Inc. from January 2021 to March 2025.
Brown receives non-employee director compensation under the Board of Directors Compensation Policy; the filing reports no related party transactions.
Beacon Financial Corporation entered into an employment agreement with Sean A. Gray, effective September 21, 2026, tied to his previously announced appointment as President and Chief Executive Officer of the Company and Beacon Bank & Trust. The filing sets his $1,000,000 base salary, a bonus target of 75% of base salary, and severance terms that increase if a termination follows a change in control.
Base salary of $1,000,000; annual bonus target of 75% of base salary
Annual equity awards with grant date fair value of 105% of base salary, plus a one-time restricted stock award of $275,000 vesting in three equal tranches
Severance on termination without cause or for good reason: two times base salary plus target bonus, rising to three times if within 24 months after a change in control
Ocean Capital Acquisition Corp's chief executive, chairman and director Kin (Stephen) Sze resigned effective October 30, 2026, and independent director Pok Yu (Augustine) Chow also resigned that day. On November 2, 2026, the board appointed Yiyan Li as CEO, chairman and director, and Stephen J. Posner as an independent director; Ms. Li will also act as principal financial officer until a chief financial officer is appointed.
Stephen Sze resigned as CEO, chairman and director on October 30, 2026; the filing says the resignation did not involve any disagreement with the company.
Augustine Chow resigned as independent director and from the Audit, Corporate Governance and Nominating, and Compensation committees on October 30, 2026.
Yiyan Li was appointed CEO, chairman and director on November 2, 2026, and serves as principal financial officer until a CFO is named.
Stephen J. Posner was appointed independent director on November 2, 2026, and joined the Audit, Corporate Governance and Nominating, and Compensation committees.
BGC Group announced that JP Aubin will step down from his Co-Chief Executive Officer role, his CEO of EMEA role, his Co-Global Head of Financial Services Brokerage role, and his executive officer position, effective at the close of business on December 31, 2026, when he becomes Vice Chairman. John J. Abularrage and Sean A. Windeatt will continue as Co-CEOs overseeing all regions and businesses, and the company says its strategy is unchanged. The filing contains no financial figures, so the change's effect on results is not quantified.
Effective date: close of business on December 31, 2026, when Aubin becomes Vice Chairman and reports to the Co-CEOs
Aubin steps down as Co-CEO, CEO of EMEA, Co-Global Head of Financial Services Brokerage, and executive officer
John J. Abularrage and Sean A. Windeatt continue as Co-CEOs overseeing all regions and businesses
Employment agreement amendment with BGC Brokers LP, Succursale de Genève dated October 28, 2026; press release issued November 3, 2026
Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., who had served as interim CEO since May 4, 2026, as President and Chief Executive Officer effective immediately, and added her to the Board. The Board reduced its size from six to five seats and is searching for an additional independent director. Her base salary remains $500,000 with an anticipated bonus of 30% of base salary, and the Board plans to review her employment agreement; the filing contains no financial results.
Appointed CEO and President effective immediately, with appointment dated November 1, 2026
Served as interim CEO since May 4, 2026; previously Senior Vice President, Clinical Development from November 2023 to May 2025
Annual base salary remains $500,000; anticipated bonus is 30% of base salary
Board reduced from six to five seats; search underway for an independent director to fill the fifth seat
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.